Bolt Biotherapeutics Inc. (NASDAQ: BOLT)
$0.74
+0.0064 ( +0.87% ) 92.8K
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
Market Data
Open
$0.74
Previous close
$0.73
Volume
92.8K
Market cap
$28.11M
Day range
$0.73 - $0.74
52 week range
$0.71 - $1.56
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
5 | Other | 1 | Feb 06, 2024 |
5 | Other | 1 | Feb 06, 2024 |
5 | Other | 1 | Feb 06, 2024 |
4 | Insider transactions | 1 | Dec 13, 2023 |
4 | Insider transactions | 1 | Dec 01, 2023 |
4 | Insider transactions | 1 | Nov 22, 2023 |
4 | Insider transactions | 1 | Nov 22, 2023 |
4 | Insider transactions | 1 | Nov 20, 2023 |
4 | Insider transactions | 1 | Nov 20, 2023 |
10-q | Quarterly Reports | 60 | Nov 09, 2023 |